Due to advances in technology and breakthroughs in early diagnosis, diagnostics has seen a significant increase in its value over the years. The industry will continue to grow with the growing need to rapidly diagnose deadly infectious diseases such as COVID-19. We think that it might be wise to place your money on solid stocks like Agilent and Mettler Toledo (NYSE). These stocks are rated ‘Strong Buy’ in our proprietary POWR Ratings system. Let’s talk about it. The diagnostics and research sector has grown significantly over the last few years thanks to the ability to predict acute illnesses early and ongoing research breakthroughs. Increasing investments in the healthcare sector and the integration of advanced technologies make the industry’s long-term prospects bright.

In the past year, the COVID-19 epidemic has seen a rapid increase in diagnostics and research. In fact, between 2022-2030 the COVID-19 global diagnostics market will grow at a strong CAGR. From 2021 to 2030, the market for infectious diseases diagnostics is expected to expand at 6.8%.

So, we believe Agilent Technologies, Inc. (NYSE) is one of the most fundamentally sound stocks. Mettler-Toledo International Inc . MTD could be a solid investment now. Our proprietary POWR Ratings system has rated these stocks ‘Strong Buy.’

Continue reading on StockNews